IBA – ACQUISITION OF OWN SHARES Immediate Release – May 12th, 2025 Louvain-la-Neuve, Belgium, May 12th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from March 25...
IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 12 mai 2025 Louvain-la-Neuve, Belgique, 12 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 24 mars 2025. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 650.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 31 décem...
IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, May 12th, 2025 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on May 12th, 2025. In its notification, FMR LLC indicated that following an acquisition or disposal of s...
IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 mai 2025, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le leader mondial des technologies d’accélération de particules, annonce devoir effectuer une notification en matière de transparence conformément à l'article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes (« loi transparence »), à la suite d’une notification reçue le 12 mai 2025. Dans sa notifi...
CONVENING NOTICE TO THE ORDINARY GENERAL MEETING 2025 OF IBA SA – WEDNESDAY, JUNE 11, 2025, AT 10:00 A.M. – Dear Shareholder, We have the honor of convening you to the Ordinary General Meeting (the "OGM") of IBA to be held on Wednesday June 11, 2025 at 10:00 A.M., to deliberate on the attached agenda. The OGM will be held in person at the Company's headquarters. There will also be an online webcast, accessible upon prior registration, but it will not be possible to vote online. This is a simple webcast. Shareholders are strongly encouraged to vote in advance of the OGM, within the leg...
CONVOCATION À L’ASSEMBLÉE GÉNÉRALE ORDINAIRE 2025 D’IBA SA - MERCREDI 11 JUIN 2025 À 10H00 - Cher Actionnaire, Nous avons l’honneur de vous convoquer à l’Assemblée Générale Ordinaire (l’« AGO ») des actionnaires d’IBA qui se tiendra le mercredi 11 juin 2025 à 10h00, pour délibérer sur l’ordre du jour détaillé ci-joint. L’AGO sera organisée en présentiel au siège de la Société. Une retransmission est également prévue en ligne, accessible sur inscription préalable, mais il ne sera pas possible de voter en ligne. Il s’agit d’une simple retransmission. Les actionnaires sont fortement encou...
Arcadis 1Q25 trading update was broadly in line. Revenues were flat organically and landed at €972m (vs. our €968m and CSS of €973m). Operating EBITA stood at €106m in line with consensus of €105m and somewhat below our €112mE. Posted margins are up 20bps in spite of flat revenue evolution. Some €21m non operating costs hit the P&L linked to restructurings and right sizing in the UK & Australian market. BtB of 1.11x (from 1.17x 1Q24) and BL of €3699m up 14% y/y and 2.8% q/q.
Ahold Delhaize: Strong 1Q25 in the US, additional details on FY25 guidance. Arcadis: Mixed start to FY25, US not to blame. PostNL: Highlights of 1Q25 analyst meeting. Sif Group: Preview - EBITDA capacity of new factory is key. Vonovia: Good results, positive message about valuations, new CEO. Wolters Kluwer: 1Q25 trading update – good start to the year
Arcadis Trading Update Q1 2025: Robust performance with continued margin expansion and backlog growth PRESS RELEASE Arcadis First Quarter 2025 Trading UpdateRobust performance with continued margin expansion and backlog growth Net Revenues of €972 million, stable year-on-yearOrder Intake of €1.1 billion, resulting in record Backlog of €3.7 billion with 2.8% organic growth1) ytdOperating EBITA Margin2) expanded to 10.9% (Q1‘24: 10.7%), investments in line with strategyKUA and WSP Infrastructure Eng. GmbH acquisitions unlocking growth opportunities in GermanyOn track to achieve the st...
IBA – ACQUISITION OF OWN SHARES Immediate Release – May 5th, 2025 Louvain-la-Neuve, Belgium, May 5th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from March 25th...
IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 5 mai 2025 Louvain-la-Neuve, Belgique, 5 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 24 mars 2025. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 650.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 31 décembre...
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning Louvain-la-Neuve, Belgium, 3 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global leading provider of dosimetry and quality assurance (QA) solutions, today announces the launch of its QUASAR® GRID3D Advantage Image Distortion Analysis System at the European Society for Radiotherapy and Oncology (ESTRO) 2025 Annual Congress in Vienna, Au...
IBA lance QUASAR® GRID3D Advantage, un système d'analyse de distorsion d'image Nouvelle norme pour l'assurance qualité de la distorsion de l'image pour la radiothérapie guidée par résonnance magnétique et la simulation de plan de traitement Louvain-la-Neuve, Belgique, le 3 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et l'un des principaux fournisseurs de solutions de dosimétrie et d'assurance qualité (QA), annonce aujourd'hui le lancement de son système d’analyse de distorsion d’image QUASAR® GRID3D Advantage lors d...
IBA launches myQA Blue Phantom³ for radiation therapy quality assurance Fastest automatic levelling offering on the market Seamless integration with all linear accelerators Louvain-la-Neuve, Belgium, 2 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a leading provider of dosimetry and quality assurance (QA) solutions, announces the launch of myQA Blue Phantom³ at the European Society for Radiotherapy and Oncology (ESTRO) 2025 annual congress in Vienna, Austria. This innovative solution is set to transform the field of radiother...
IBA lance myQA Blue Phantom³ pour l'assurance qualité en radiothérapie L'offre de nivellement automatique la plus rapide du marché Intégration aisée avec tous les accélérateurs linéaires Louvain-la-Neuve, Belgique, le 2 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et l'un des principaux fournisseurs de solutions de dosimétrie et d'assurance qualité (QA), annonce le lancement de myQA Blue Phantom³ lors du congrès annuel 2025 de la Société européenne de radiothérapie et d'oncologie (ESTRO) à Vienne, en Autriche. Cette ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.